Preferred Label : asunaprevir;

MeSH note : an NS3 protease inhibitor against hepatitis C virus;

CISMeF synonym : BMS-650032;

MeSH hyponym : BMS 650032;

MeSH CAS label : cyclopropanecarboxamide, N-((1,1-dimethylethoxy)carbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, (1R,2S)-;

Is substance : O;

UNII : S9X0KRJ00S;

Details


Main resources

You can consult :


SUNVEPRA - Summary Basis of Decision (SBD)
Asunaprevir, 100 mg , capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00297
2016
false
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
asunaprevir
asunaprevir
NS3 protein, hepatitis C virus
risk assessment
drug evaluation
drug approval
canada
adult
hepatitis C, chronic
drug therapy, combination
Hepatitis C virus genotype 4 (organism)
Hepatitis C virus genotype 1 (organism)
Cirrhosis of liver due to chronic hepatitis C (disorder)
antiviral agents
antiviral agents
protease inhibitors
protease inhibitors
treatment outcome
asunaprevir
isoquinolines
sulfonamides
isoquinolines
sulfonamides
viral nonstructural proteins

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.